VGLL3 and metabolic dysfunction-associated steatohepatitis: Vgll3 expression was also increased in the fibrotic liver of non-alcoholic steatohepatitis (NASH) model mice (Supplementary Fig. 4d), specifically in hepatic stellate cells expressing Desmin (Supplementary Fig. 4e).